Kesavan Esuvaranathan

NRAMP1 and hGPX1 gene polymorphism and response to bacillus Calmette-Guérin therapy for bladder cancer.

The signalling pathway for BCG-induced interleukin-6 production in human bladder cancer cells.

N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells.

Asian trends in prostate cancer hormone therapy.

Nonviral cytokine gene therapy on an orthotopic bladder cancer model.

The 2nd conference on Asian trends in prostate cancer hormone therapy.

Non-viral tumor necrosis factor-alpha gene transfer decreases the incidence of orthotopic bladder tumors.

Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter.

Randomized controlled study of mechanical percussion, diuresis, and inversion therapy to assist passage of lower pole renal calculi after shock wave lithotripsy.

Predictive value of p53 and pRb expression in superficial bladder cancer patients treated with BCG and interferon-alpha.

The 5th Conference on Asian Trends in Prostate Cancer Hormone Therapy.

Internalization of Mycobacterium bovis, Bacillus Calmette Guerin, by bladder cancer cells is cytotoxic.

Debulking nephrectomy followed by a "watch and wait" approach in metastatic renal cell carcinoma.

New therapies for non-muscle-invasive bladder cancer.

Noninvasive urinary metabonomic diagnosis of human bladder cancer.

Metabolic footprinting of tumorigenic and nontumorigenic uroepithelial cells using two-dimensional gas chromatography time-of-flight mass spectrometry.

Unique case of tubulocystic carcinoma of the kidney with sarcomatoid features: a new entity.

Tumor and microenvironment modification during progression of murine orthotopic bladder cancer.

Bacillus Calmette-Guérin induces cellular reactive oxygen species and lipid peroxidation in cancer cells.

An automated Pearson's correlation change classification (APC3) approach for GC/MS metabonomic data using total ion chromatograms (TICs).

Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.

Health-related quality of life and psychological well-being in patients with benign prostatic hyperplasia.

Metabonomic profiling of bladder cancer.

Embryonal rhabdomyosarcoma of the adult urinary bladder: a rare case report of misclassification as inflammatory myofibroblastic tumor.

Metabolic signatures of renal cell carcinoma.

Metabonomic diagnosis of bladder cancer: what are the advantages and considerations?

Local Immune Stimulation by Intravesical Instillation of Baculovirus to Enable Bladder Cancer Therapy.

Editorial comments on: Seventeen-year follow-up of the prospective randomized Nordic CIS study: BCG monotherapy versus alternating therapy with mitomycin C and BCG in patients with carcinoma in situ of the urinary bladder, by E. Kaasinen et al. (in this issue).